The osseointegration
implants market
is being positively influenced by the increasing volume of dental implant
surgeries and trauma incidents, rising prevalence of spinal cord injuries
(SCIs), growing funds for research, and improved reimbursement support for
surgeries. It generated a revenue of $9.9 billion in 2017 and is expected to
advance at a 4.0% CAGR during the forecast period (2018–2023). Osseointegration
implants are used for the treatment of hearing loss, tooth loss, and amputees.
Osteoblasts and supporting tissue migrate to the pore in which the implant is
placed.
Rise in new
product launches in the osseointegration implants market is another trend.
Companies are unveiling new and innovative products to increase their portfolio
and geographical presence. For instance, the OKTAGON implant system developed
by DRS International GmbH was launched by Henry Schein Inc. in September 2017
with exclusive distribution rights in the U.K. Similarly, OPRA Implant System
Platform G was launched by Integrum AB in January 2017. It is used for
transfemoral patients to simplify surgical procedures and improve the
mechanical performance of the system.
Download Report Sample at: https://www.psmarketresearch.com/market-analysis/osseointegration-implants-market/report-sample
The largest
contributor to the osseointegration implants market in 2017 in the region segment
was North America. A United Nations publication, “An Aging World 2017”,
mentioned that the aged population (60 years and above) in the region is
expected to grow to 28.0% of total by 2050 from 22.0% in 2017. Hence, it is
clear that the North American market is being driven by the increasing aged
population, along with the rising volume of amputations and surging prevalence
of spinal disorders.
Therefore,
the market for osseointegration implants is slated to advance in the forecast
period, as the incidence of SCIs and the number of amputations are witnessing
an increase.
